Hospital Universitario De Leon

At Hospital Universitario De Leon, research in cardiology focuses on major cardiovascular diseases such as atherosclerotic cardiovascular disease, coronary artery disease, and atrial fibrillation. These trials are largely aimed at testing new ways to prevent serious events like stroke, heart attack, and other complications.

• Preventing ischemic stroke in people with atrial fibrillation or after a recent stroke
• Lowering cardiovascular risk in patients with ASCVD and elevated lipoprotein(a)
• Evaluating new treatments to reduce major adverse cardiovascular events
• Studying antiplatelet strategies after coronary stent implantation

This area combines treatment innovation with efforts to improve long-term protection for patients at high risk of cardiovascular events.

The site also supports studies in hematologic cancers, including follicular lymphoma and marginal zone lymphoma. These trials are designed to compare treatment options and identify more effective approaches for patients with relapsed or refractory disease.

• Comparing new lymphoma treatment combinations with established therapies
• Improving outcomes for relapsed or refractory follicular lymphoma
• Improving outcomes for relapsed or refractory marginal zone lymphoma

This research reflects a focus on better disease control and more effective cancer care in hematology.

Clinical trials in neoplasms at Hospital Universitario De Leon include breast cancer and endometrial cancer. The studies are exploring new endocrine-based and targeted approaches, as well as follow-up research to understand recurrence patterns over time.

• Testing new strategies to prevent breast cancer recurrence
• Evaluating treatments for early-stage ER+/HER2- breast cancer
• Studying tumor response in invasive breast cancer
• Assessing maintenance treatment options for advanced or recurrent endometrial cancer

The main goal is to refine cancer treatment and improve long-term outcomes for patients with solid tumors.

Research in nutritional and metabolic diseases includes type 2 diabetes, obesity, and overweight. These trials are evaluating new therapies that may help improve metabolic control and reduce related health risks.

• Testing treatments for adults with type 2 diabetes and excess weight
• Exploring therapies that may support weight and glucose management
• Assessing approaches that could lower long-term metabolic complications

This area highlights efforts to improve everyday disease management and reduce the burden of metabolic disorders.